Bone Biologics Corp (BBLGW) Accounts Payables (2013 - 2025)
Bone Biologics (BBLGW) posted quarterly Accounts Payables of $417884.0 for Q4 2025, up 12.02% year-over-year from $373042.0 in Q4 2024, and up 25.46% quarter-over-quarter from $333081.0 in Q3 2025.
Bone Biologics Corp (BBLGW) Accounts Payables (2013 - 2025) Analysis & Trends
Bone Biologics (BBLGW) has reported Accounts Payables for 13 consecutive years, with $417884.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Accounts Payables rose 12.02% year-over-year to $417884.0; the TTM figure through Dec 2025 stood at $417884.0 (up 12.02% YoY), while the FY2025 annual figure was $417884.0, up 12.02% from the prior year.
- Accounts Payables rose to $417884.0 in Q4 2025 per BBLGW's latest filing, from $333081.0 in the prior quarter.
- Across five years, Accounts Payables topped out at $2.3 million in Q1 2023 and bottomed at $54913.0 in Q1 2022.
- Historically, Accounts Payables has averaged $478146.7 across 5 years, with a median of $290462.0 in 2025.
- Annual changes were most pronounced in 2023 — Accounts Payables jumped 4050.55% — and 2024, when it tumbled 93.59%.
- Bone Biologics' Accounts Payables stood at $99909.0 in 2021, then increased by 4.88% to $104786.0 in 2022, then soared by 244.19% to $360662.0 in 2023, then gained by 3.43% to $373042.0 in 2024, then climbed by 12.02% to $417884.0 in 2025.
- Business Quant data shows BBLGW's Accounts Payables at $417884.0 in Q4 2025, $333081.0 in Q3 2025, and $403729.0 in Q2 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 417,884.00 |
| Sep 30, 2025 | 333,081.00 |
| Jun 30, 2025 | 403,729.00 |
| Mar 31, 2025 | 247,843.00 |
| Dec 31, 2024 | 373,042.00 |
| Sep 30, 2024 | 190,057.00 |
| Jun 30, 2024 | 231,872.00 |
| Mar 31, 2024 | 146,186.00 |
| Dec 31, 2023 | 360,662.00 |
| Sep 30, 2023 | 1.10 Mn |
| Jun 30, 2023 | 1.69 Mn |
| Mar 31, 2023 | 2.28 Mn |
| Dec 31, 2022 | 104,786.00 |
| Sep 30, 2022 | 799,475.00 |
| Jun 30, 2022 | 70,636.00 |
| Mar 31, 2022 | 54,913.00 |
| Dec 31, 2021 | 99,909.00 |
| Sep 30, 2021 | 70,275.00 |
| Jun 30, 2021 | 84,237.00 |
| Mar 31, 2021 | 503,337.00 |